In this context, we recently reported that ETAR co-opts Wnt/Δ-catenin signaling, which is a critical driver of EOC chemoresistance [37], to acquire a chemoresistant and mesenchymal phenotype, thus sustaining tumor progression through a self-strengthening feedback loop [8]. The gene discussed is EDNRA; the disease is neoplasm.